~~<i id='4237DA136D'><strike id='4237DA136D'><tt id='4237DA136D'><pre id='4237DA136D'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：fashion 2025-10-01 20:18:06 Page View：95954

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： UnitedHealth’s Optum accused of antitrust violations in California
Next article： At least 13 dead in Texas as scorching temps continue

explore

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

UnitedHealth’s Optum accused of antitrust violations in California

EmanateHealthsuedUnitedHealth'sOptum,allegingtheinsurerpushedittoagreenottocompeteforprimarycarephys

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

CDC director unscathed in first congressional testimony

CDCDirectorMandyCohenWinMcNamee/GettyImagesWASHINGTON—HouseRepublicanssoughtThursdaytohammertheCente